- Country: Ukraine
- Summary: Chloramphenicol Eye Drops 0.25%; Chloropyramine, Solution for Injection, 20 Mg/Ml, 1 Ml Each; Cholecalciferol, Tablets (Capsules), 4000 Iu; Choline Alfoscerate, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Holi...
- UAT Ref No: 132302697
- Deadline: 22 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 84000
- Notice Type: Tender
- Document Ref. No.: UA-2025-12-17-022529-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Chloramphenicol eye drops 0.25%; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Cholecalciferol, tablets (capsules), 4000 IU; Choline alfoscerate, solution for injection, 250 mg/ml, 4 ml each; Choline alfoscerate, capsules, 400 mg each; Celecoxib, capsules, by 100 mg; Celecoxib, capsules, 200 mg each; Cefoperazone, powder for injection 1 g; Cefuroxime film-coated tablets, 500 mg each; Cefoperazone/Sulbactam, powder for injections/infusions 1g/1g; Dexpanthenol foam for the skin 50 mg/g of 58 g; Chloropyramine, tablets, by 25 mg; Dexketoprofen granules for oral solution 25 mg each; Dexketoprofen film-coated tablets 25 mg; Diclofenac eye drops 1 mg/ml, 5 ml each; Diosmin (combinations), tablets, 1000 mg each; Esomeprazole tablets/capsules of 20 mg; Esomeprazole 40 mg tablets/capsules; Glimepiride, tablets, 3 mg each; Glimepiride, tablets, 4 mg each; Human insulin (Combination: 30% Short-acting; 70% Medium-acting), suspension for injection, 100 U/ml, bottle, 5 ml; Human insulin (Medium duration of action), suspension for injection, 100 U/ml, bottle, 5 ml each; Human insulin (short-acting), solution for injection, 100 units/ml, vial, 5 ml each; Interferon alfa-2b, rectal suppositories, 1 million IU each; Arginine aspartate oral solution 200 mg/ml 100 ml each; Mexidol solution for injection, 50 mg/ml in 2 ml; Oseltamivir tablets/capsules of 75 mg; Oxymetazoline nasal spray 0.5 mg/ml in 10 ml; Oxymetazoline nasal drops 0.5 mg/ml, 10 ml each; Metamizole n... Type of purchase: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Name Classifier and its corresponding code Quantity/Measurement units Place of delivery Date of delivery Name Chloramphenicol eye drops 0.25%, Chloropyramine, solution for injection, 20 mg/ml, 1 ml each, Cholecalciferol, tablets (capsu...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINChloramphenicol Eye Drops 0.25%; Chloropyramine, Solution for Injection, 20 Mg/Ml, 1 Ml Each; Cholecalciferol, Tablets (Capsules), 4000 Iu; Choline Alfoscerate, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Holi... - Ukraine Tender
The MUNICIPAL ENTERPRISE "CITY COMMUNAL PHARMACY", a Government sector organization in Ukraine, has announced a new tender for Chloramphenicol Eye Drops 0.25%; Chloropyramine, Solution for Injection, 20 Mg/Ml, 1 Ml Each; Cholecalciferol, Tablets (Capsules), 4000 Iu; Choline Alfoscerate, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Holi.... This tender is published on UkraineTenders under UAT Ref No: 132302697 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-22.
The estimated tender value is UAH 84000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
